JK
James R. Kasinger (General Counsel and Secretary) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $626K of CRSP (10,400 sh × $60.24, as filed), executed Sep 22. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Oct 6
Filed Oct 8
Median ADV $94.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
CRSPRecent filings
CRSPSALE
CRISPR Therapeutics AG
View filing →
$119K1,990 sh × $60.04
Exec Oct 6
Filed Oct 8 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $626K
10,400 sh × $60.24
Exec Sep 22
Filed Sep 24 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $149K
3,182 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $166K
3,450 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $148K
2,800 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $111K
2,112 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $131K
3,185 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $121K
2,850 sh × $42.42
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET More filings →